Print This Page Print This PageEmail to a Friend Email This Page
December 11, 2017 - GYN oncologist Pierce joins MCI to lead Cancer Control and Prevention

Young Pierce 847.jpg

MOBILE, Alabama -- Dr. Jennifer Young Pierce, a gynecologic oncologist with a research interest in cervical cancer, has joined USA Mitchell Cancer Institute as the leader of Cancer Control and Prevention and professor of interdisciplinary clinical oncology.

Pierce comes to MCI from Hollings Cancer Center at the Medical University of South Carolina, where she served as GYN Oncology Disease team leader and associate professor in obstetrics and gynecology.

“Without question, Dr. Pierce adds a significant depth and breadth to our growing Gynecologic Oncology division as well as the MCI,” said Dr. Rodney P. Rocconi, chief of Gynecologic Oncology. "Her expertise in cancer control and prevention research, particularly her work in HPV vaccination in South Carolina, has garnered national attention. We’re excited that she will bring her experience to Alabama and the Gulf Coast region."

With a degree in medicine from MUSC and degrees in engineering and public health from the University of Virginia Charlottesville, Pierce became the first female gynecologic oncologist in South Carolina in 2009. While in residency and fellowship at Brigham and Women’s Hospital/Massachusetts General/Harvard University and the University of Virginia, she developed an active research interest in cervical cancer and HPV treatment and prevention.

Vaccination against HPV, the human papillomavirus, can help prevent cervical cancer and is recommended by the CDC for boys and girls ages 9 through 14..

“At the moment, the best data puts Alabama at the center of the pack for the Southeast in HPV vaccination rates,” she said. “Unfortunately, we see high rates of HPV-related disease and terribly high rates of mortality from cervical cancer. In some counties, it approaches that of third world countries.”

While at the University of Virginia, Pierce took multiple trips to Africa to run a cervical cancer screening trial, the first of its kind to test the rapid HPV test in Africa.

She serves on the National HPV Roundtable, and on cervical cancer and immunotherapy committees for the NRG Oncology, the cooperative clinical trials group of the National Cancer Institute.

Pierce treats patients suffering from gynecologic malignancies, including all medical and surgical aspects. She is board certified in Obstetrics and Gynecology and Gynecologic Oncology.

USA Mitchell Cancer is the only academic cancer research and treatment facility on the upper Gulf Coast corridor.

Email Newsletters

Connect With Us